EP2129467A2 - Pulvérisateur et procédé de préparation du traitement d'un échantillon biologique - Google Patents
Pulvérisateur et procédé de préparation du traitement d'un échantillon biologiqueInfo
- Publication number
- EP2129467A2 EP2129467A2 EP08735665A EP08735665A EP2129467A2 EP 2129467 A2 EP2129467 A2 EP 2129467A2 EP 08735665 A EP08735665 A EP 08735665A EP 08735665 A EP08735665 A EP 08735665A EP 2129467 A2 EP2129467 A2 EP 2129467A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- sample
- vessel
- pulverizer
- movable body
- cooled
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 36
- 239000012472 biological sample Substances 0.000 title claims description 14
- 239000000523 sample Substances 0.000 claims abstract description 67
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 6
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 6
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 6
- 238000002955 isolation Methods 0.000 claims abstract description 5
- 108091005461 Nucleic proteins Proteins 0.000 claims abstract description 4
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 4
- 239000012805 animal sample Substances 0.000 claims abstract description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 32
- 210000001519 tissue Anatomy 0.000 claims description 27
- 239000007788 liquid Substances 0.000 claims description 17
- 239000004033 plastic Substances 0.000 claims description 17
- 229920003023 plastic Polymers 0.000 claims description 17
- 229910052757 nitrogen Inorganic materials 0.000 claims description 16
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 11
- 235000011089 carbon dioxide Nutrition 0.000 claims description 11
- 239000002184 metal Substances 0.000 claims description 11
- 230000029087 digestion Effects 0.000 claims description 10
- 210000004185 liver Anatomy 0.000 claims description 6
- 239000000126 substance Substances 0.000 claims description 6
- 210000000988 bone and bone Anatomy 0.000 claims description 5
- 238000001816 cooling Methods 0.000 claims description 5
- 235000013311 vegetables Nutrition 0.000 claims description 4
- 230000006641 stabilisation Effects 0.000 claims description 3
- 238000011105 stabilization Methods 0.000 claims description 3
- 239000007853 buffer solution Substances 0.000 claims description 2
- 239000012520 frozen sample Substances 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims 2
- 239000000470 constituent Substances 0.000 claims 1
- 229910052500 inorganic mineral Inorganic materials 0.000 claims 1
- 239000011707 mineral Substances 0.000 claims 1
- 230000000007 visual effect Effects 0.000 claims 1
- 239000000243 solution Substances 0.000 description 12
- 239000000872 buffer Substances 0.000 description 11
- 241000196324 Embryophyta Species 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 239000011543 agarose gel Substances 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 239000004570 mortar (masonry) Substances 0.000 description 3
- 239000002953 phosphate buffered saline Substances 0.000 description 3
- 238000010298 pulverizing process Methods 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000012139 lysis buffer Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000011534 wash buffer Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 238000007399 DNA isolation Methods 0.000 description 1
- 102000007260 Deoxyribonuclease I Human genes 0.000 description 1
- 108010008532 Deoxyribonuclease I Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 108020002230 Pancreatic Ribonuclease Proteins 0.000 description 1
- 102000005891 Pancreatic ribonuclease Human genes 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 239000008049 TAE buffer Substances 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- HGEVZDLYZYVYHD-UHFFFAOYSA-N acetic acid;2-amino-2-(hydroxymethyl)propane-1,3-diol;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid Chemical compound CC(O)=O.OCC(N)(CO)CO.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O HGEVZDLYZYVYHD-UHFFFAOYSA-N 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 210000001520 comb Anatomy 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 238000012864 cross contamination Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 210000005003 heart tissue Anatomy 0.000 description 1
- 238000010562 histological examination Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000012212 insulator Substances 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000005464 sample preparation method Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000007779 soft material Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B02—CRUSHING, PULVERISING, OR DISINTEGRATING; PREPARATORY TREATMENT OF GRAIN FOR MILLING
- B02C—CRUSHING, PULVERISING, OR DISINTEGRATING IN GENERAL; MILLING GRAIN
- B02C17/00—Disintegrating by tumbling mills, i.e. mills having a container charged with the material to be disintegrated with or without special disintegrating members such as pebbles or balls
- B02C17/14—Mills in which the charge to be ground is turned over by movements of the container other than by rotating, e.g. by swinging, vibrating, tilting
Definitions
- the invention relates to a method for the preparation of a vegetable or animal sample for processing, ie, for example, for the isolation of nucleic acids or proteins from the sample and a pulverizer.
- a method for the preparation of a vegetable or animal sample for processing ie, for example, for the isolation of nucleic acids or proteins from the sample and a pulverizer.
- Such preparations and examinations are carried out in a laboratory by a laboratory assistant or a laboratory technician on the basis of standardized work instructions.
- Such a manual includes a so-called protocol.
- An example of such a protocol for the isolation of plasmid DNA from E. coli is apparent from the document DE 1 01 53 957 Al.
- kits can be obtained commercially, for example the "UltraClean Tissue DNA Isolation Kit” of the company, depending on the sample and the desired result.
- Qiagen www.Qiagen.com
- a sample is processed using such a kit according to a given protocol, it must be suitably prepared.
- an organ is taken from a test animal, such as a rat. It depends on the objective, which organ of an animal is selected.
- the removed tissue of the animal is washed in a washing buffer solution, for example in PBS (Phosphate Buffered Saline with the following contents: Na 2 HPO 4 (dried), NaH 2 PO 4 (dried), NaCl and distilled water).
- a washing buffer solution for example in PBS (Phosphate Buffered Saline with the following contents: Na 2 HPO 4 (dried), NaH 2 PO 4 (dried), NaCl and distilled water).
- tissue with a body temperature of, for example, 37 ° C is immersed in liquid nitrogen. Bubbles develop. The tissue is only removed from the liquid nitrogen when bubbling stops. Subsequently, the tissue is stored at -80 0 C, for example, with the aid of dry ice.
- RNAIater® is a viscous liquid developed by Ambion (www.ambion.com) for the preservation of fresh tissue.
- the preservative effect is based primarily on the fact that all enzymes inactivated by dehydration in the tissue and cell activities are stopped.
- the viscous fluid must quickly diffuse into all cells of the tissue.
- the size of the fabric pieces is therefore limited to an edge length of a maximum of half a centimeter.
- the tissue thus treated is also cooled at -80 ° to store it until processing.
- tissue For processing typically 10 to 100 mg of tissue is needed to perform the desired assay, isolation or the like. It is now separated before starting the processing, the required amount of animal tissue, for example, with a scalpel.
- the separated sample, ie the separated tissue is now digested, that is, the cell walls must be opened. This can be done mechanically, chemically or enzymatically. Mechanical disruption takes place, for example, with the aid of a "TissueRuptor" from Qiagen, which is known from the TissueRuptor Handbook, July 2006 by Qiagen, in which a rotating knife with 35,000 revolutions per minute shatters cell walls of the tissue.Mechanical digestions are regularly carried out in a buffer. to avoid damage to the ingredients such as nucleic acids.
- a sample is first blocked in paraffin and then cut into thin tissue layers by means of a microtome. If vegetable samples are to be processed, scalping can only be done with soft materials such as leaves, soft beans, etc. For dried or frozen plant samples, they are cooled in liquid nitrogen and ground in a liquid nitrogen cooled mortar using a pestle.
- German Patent 738,286 teaches to freeze and grind cells together with a dispersion liquid so as to comminute cells.
- a solution to the problem comprises the features of claim 1.
- Other solutions include the features of the dependent claims, which are also directed to a method.
- An apparatus for carrying out the method comprises the features of the last subsidiary claim.
- a sample is first washed as described above and treated, for example, with liquid nitrogen or stored in RNAIater.
- a closable preferably made of metal vessel or plastic existing vessel, which is equipped with a metal inlay, and a container located in the body, movable body cooled to a temperature which is well below 0 0 C.
- the plastic container is a shell for the inlay.
- An inlay is a body made separately from the shell. To distinguish this is a double-walled vessel, as it is known for example from the document US 6,235,501 B l, Figure 1 0, which does not include inlay in the sense of the present invention, since the two known vessel walls are integrally connected to each other.
- the temperature to which the vessel is cooled should be at least -50 0 C.
- a temperature of approx. - 80 0 C for example, from -70 0 C to -90 0 C to choose, since this is significantly further away from 0 ° C.
- Dry ice can be provided inexpensively. It has been shown that cooling to approx. -80 0 C for particularly good results. Lower temperatures than -80 0 C up to a certain extent possible. It should be noted, however, that the vessel must not be allowed to cool too much. Thus, a temperature of liquid nitrogen, ie of -1 96 0 C has been found to be too low to get good results.
- the interior of the vessel is dimensioned and designed in addition to the movable body therein.
- Particularly suitable is a cylindrical interior with hollow spherical ends.
- the movable body is then preferably a ball or a bolt with spherical ends.
- the diameter the ball or the bolt is smaller than the diameter of the interior, so as to ensure the mobility.
- the movable body is made of a hard, preferably heavy material such as metal in order to be able to crush the sample.
- the biological sample for example a cooled rat heart, is preferably placed completely in the vessel without first chopping the sample in order to obtain good results.
- a least -50 0 C cold sample is placed into the vessel.
- the vessel is shaken for 10 to 30 seconds, in particular by hand, so that the movable body is hurled back and forth.
- the thus crushed sample is removed and the desired amount is processed using a kit according to a protocol.
- Seeds of plants can be prepared in this way for further processing. For skin and bone and comparatively hard or viscous samples, however, this method is not suitable.
- the sample is in powder form, it advantageously has a particularly large surface area, from which subsequently used chemicals can attack.
- a desired amount of powder can be provided particularly easily for subsequent steps, for example by weighing or even by appropriately sized measuring vessels, such as a measuring spoon.
- Figure 1 shows in section a vessel 1, on which a cover 2 can be screwed.
- a ball 3 which has a smaller diameter compared to the diameter of the vessel 1.
- the diameter of the vessel is in the range of a few centimeters.
- the interior of the vessel 1 is cylindrical. When closed, the ends are 5 and 6 of the vessel spherically shaped. By appropriate shaking of the vessel 1, the ball 3 is moved back and forth in the interior and strikes the ends 5 and 6.
- the vessel 1, the lid 2 and the ball 3 are made of metal and that made of stainless steel.
- the vessel is cooled in dry ice at -80 0 C.
- a sample 7 is taken from an animal.
- the sample is washed and immersed in nitrogen until no more bubbles form or stored in RNAIater for 24 hours, for example. Following this, the sample may initially be stored in dry ice at -80 0 C.
- dry ice In the case of a plant dried plant tissue such as seeds in the vessel 1 is cooled on dry ice. Fresh plant material like leaves are previously cooled to -80 0 C.
- the vessel l has been cooled to the desired temperature, this is removed by hand.
- the hand is expediently protected from the cold with a cotton glove and a glove made of latex.
- the sample 7 is placed in the vessel 1, in which the ball 3 is located.
- the lid 2 is screwed onto the vessel 1 and this closed so tightly.
- the vessel 1 is shaken by hand back and forth, so that the ball 3 impinges alternately on the two ends 5 and 6.
- the sample 7 is thereby smashed.
- the result is a free-flowing powder that can be initially stored in the vessel 1 further. It is unscrewed immediately or following storage of the lid 2 and removed the crushed sample. A desired amount can now be provided by weighing, for example.
- a liver was taken from a rat and washed in PBS. Following this, the liver was stored in RNAIater® for 24 hours. Following this, the rat liver was stored at -80 ° C until further use. The liver was crushed in the cooled, closed vessel for 20 seconds as previously described. Using a funnel, the crushed sample was placed in a Falcon tube, and further stored in dry ice at -80 0 C initially.
- the used DNeasy protocol from Qiagen includes the following steps.
- the 1 0 mg tissue is incubated with 1 80 ⁇ l of BUFFER 1 + 20 ⁇ l proteinase K at 56 ° C for one hour in a rocking platform.
- 4 ⁇ l RNase A are pipetted in and incubated for 2 minutes at room temperature.
- 200 ul AL lysis buffer
- 200 ⁇ l of ethanol (100%) are pipetted in and mixed by gentle inverting.
- the column is washed as described in the protocol with 500 ⁇ l of buffer AW 2 for 3 minutes at 1 4000 revolutions per minute. The supernatant is again discarded.
- the optional drying step described in the protocol is used for 1 minute at 1 4000 rpm.
- 200 ⁇ l of RNase-free water is pipetted into the center of the column and incubated at room temperature for 1 minute, then centrifuged at 8000 rpm for 1 minute. This eluate is measured by means of a spectrometer. This serves to determine the concentration and to determine the degree of purity.
- an agarose gel is made for qualitative and quantitative DNA determination. On this basis, the quality of the DNA, the degree of degradation, the size of the molecule and its amount can be determined.
- the bright upper regions in FIG. 2 characterize the genomic DNA.
- the bright area above TR is not as high as above TD +, TD- or TD / TR.
- Figure 2 shows images of DNA agarose gels used as described above to determine the quantity and quality of the DNA.
- a 1% gel is poured.
- 1 g of agarose powder long-chain carbohydrate molecules that can polymerize
- 1 00 ml (1 x) TAE buffer heated in the microwave.
- the resulting solution is mixed with 5 .mu.l Ethid iumbromid and mixed by shaking the flask and poured into a mold.
- the hot solution now combs are clamped, which leave as the solution cools, which polymerizes, prints in the gel, which later form the slots in which the sample mixed with 5 ⁇ l Lo ⁇ ding Dye is pipetted into it.
- a marker is additionally added to the gel for later size comparison.
- the DNA spreads after application of an electrical voltage due to its different weight and charge, d. H . Small degraded fragments move faster in the gel than high molecular weight DNA.
- the DNA obtained by the method according to the invention can be seen in the form of a cloud with the naked eye.
- Stabilization reagent has been treated, but was first frozen in liquid nitrogen. It was obtained with the aid of the method according to the invention, the double concentration of RNA compared to the known from the prior art, the method described above.
- the supernatant was then pipetted into a new 2 ml reaction tube and 0.5X volume of 96-100% ethanol pipetted in and mixed through the pipette. Subsequently, first 700 ⁇ l of the solution were pipetted into the RNeasy column and centrifuged for 1 5 seconds at 10,000 revolutions per minute. Since the column has only 700 ⁇ l capacity, this step was repeated for the remaining solution so that the entire sample was passed over the column. The supernatant after centrifugation was discarded. Thereafter, the column was washed with 350 ul buffer RWl for 1 5 seconds at 8000 g and the supernatant discarded.
- the column was then transferred once more to a new 2 ml reaction vessel and dried therein for 1 minute at maximum speed.
- the column was transferred to a new 2 ml reaction vessel and filled with 30 ⁇ l of RNase-free water and centrifuged for 1 minute at 10,000 revolutions per minute to elute.
- the eluate was then also measured by spectrometer and evaluated by RNA agarose gel.
- FIG. 3 shows a particularly preferred embodiment of a closable vessel with which a sample is pulverized.
- This vessel is called pulverizer below. It comprises an inlay 10, which preferably consists of metal for the reasons stated above.
- the inlay 10 is comprised of a shell 11 preferably made of plastic.
- the plastic shell serves primarily as an insulator to maintain the low temperature during Scblinins. Overall, the weight can be advantageously reduced in comparison to a completely made of metal pulverizer, which facilitates handling.
- the double arrow below the pulverizer shown in FIG. 3 illustrates the preferred direction of movement in order to comminute the sample 7.
- the buffers and reagents mentioned in the present application can be used in the Fa. Qiagen GmbH, Hilden, Germany, unless otherwise expressly stated.
- FIG. 4 shows a section through a further improved embodiment of the invention.
- the pulverizer comprises an inner sealable container 4 made of plastic.
- the plastic inner container adjacent to so closely to the preferably made of metal inner walls of the pulverizer, so that the plastic inner container can not be destroyed by a ball 3 or a similar means during pulverization.
- the plastic inner container 4 is removed after pulverization and can now serve as a storage vessel. Since the inner container is made of plastic, this can be made very inexpensive and therefore suitable for single use.
- the lid of the inner container closes the remaining part of the container preferably by a positive connection, or it can be screwed onto the remaining part.
- a positive connection is possible because plastic can be sufficiently elastic, so that, for example, an inwardly projecting bead of the lid snaps into a designated annular recess of the rest of the container body or vice versa, when the lid is pressed to the rest of the container body suitable.
- Such a positive connection is particularly preferable because accidental release of the lid is particularly reliably avoided.
- a container can be closed faster compared to a closure with a screw cap.
- a set comprises, in addition to a pulverizer, a multiplicity of inner containers, which are preferably optically different, for example because of differently colored covers or different embossments.
- the different optics can be used advantageously for the identification of a content.
- a red-colored container lid can be used to mark a "heart" located therein and another lid, for example a green-colored lid, to identify another organ, such as a lung, for example no longer be labeled separately, which can be problematic due to the low temperatures.
- the existing plastic plastic inner container can be made of PET, but also made of PP or PE, since such plastics are grown to the intended low temperatures in principle.
- a kit in one embodiment, includes one or more measuring spoons besides a pulverizer so as to facilitate or accelerate the removal of the required amount of sample from the pulverizer or from an inner container.
- a measuring spoon is so dimensioned and assigned to certain samples that the measuring spoon is capable of receiving a suitable amount of sample for further processing.
- a separate weighing of a sample taken from the pulverizer can thus be accelerated or even completely eliminated.
- a set comprises a plurality of optically labeled measuring spoons associated with different samples.
- a red-colored measuring spoon can be provided for the removal of a heart sample.
- the identifications of inner containers or parts of inner containers coincide with the identifications of measuring spoons.
- Such a set then also includes a predetermined assignment of identifiers to samples, that is, for example, to organs. If, for example, a green-colored measuring spoon is provided for the organ lung, then an inner container is likewise completely or partially dyed green. The dimensioning of the measuring spoon is adapted to the sample "lung.”
- the set then contains a corresponding assignment rule, which can be that a corresponding sample, for example a lung, is already displayed on the corresponding container and / or the measuring spoon.
- a set comprises, in addition to a pulverizer, a shaking apparatus to facilitate the opening of an imprinter Automated Pulveris ⁇ tor sample to perform automated.
- a shaking apparatus to facilitate the opening of an imprinter Automated Pulveris ⁇ tor sample to perform automated.
- One or more Pulverisatoren can be used in the shaker or attached to this suitable.
- the shaking apparatus comprises coolable receiving devices for receiving pulverizers.
- the shaking apparatus does not need to be digested immediately after filling the sample in the pulverizer, if it can be sufficiently cooled. So it can be a variety of
Landscapes
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Sampling And Sample Adjustment (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102007016221A DE102007016221A1 (de) | 2007-04-04 | 2007-04-04 | Pulverisator und dazugehöriges Verfahren für die Vorbereitung zur Prozessierung einer biologischen Probe |
| PCT/EP2008/053896 WO2008122550A2 (fr) | 2007-04-04 | 2008-04-02 | Pulvérisateur et procédé de préparation du traitement d'un échantillon biologique |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP2129467A2 true EP2129467A2 (fr) | 2009-12-09 |
| EP2129467B1 EP2129467B1 (fr) | 2014-07-02 |
Family
ID=39736155
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP08735665.5A Not-in-force EP2129467B1 (fr) | 2007-04-04 | 2008-04-02 | Pulvérisateur et procédé de préparation du traitement d'un échantillon biologique |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US8348183B2 (fr) |
| EP (1) | EP2129467B1 (fr) |
| JP (1) | JP5150880B2 (fr) |
| DE (1) | DE102007016221A1 (fr) |
| WO (1) | WO2008122550A2 (fr) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2503316A1 (fr) * | 2008-09-18 | 2012-09-26 | Qiagen GmbH | Procédé et dispositif pour l'ouverture simultanée automatique de plusieurs échantillons biologiques |
| US8523092B2 (en) * | 2009-09-14 | 2013-09-03 | Pioneer Hi-Bred International, Inc. | System and method for creating a test sample from individual seeds or tissue structures |
| TWM417958U (en) * | 2011-07-07 | 2011-12-11 | Rega Biotechnology Inc | Portable grinder |
| AU2012346112B2 (en) * | 2011-11-28 | 2017-03-02 | Syngenta Participations Ag | DNA extraction from seeds using osmoticum |
| FR2991305B1 (fr) * | 2012-06-01 | 2015-05-01 | Assist Publ Hopitaux De Paris | Dispositif pour le recueil, le traitement preanalytique, le transport et le broyage d'echantillons solides. |
| FR3091987B1 (fr) * | 2019-01-29 | 2021-12-03 | Peugeot Saveurs | moulin a produits condimentaires |
| US11774328B2 (en) * | 2019-02-26 | 2023-10-03 | SPEX SamplePrep, LLC | Homogenizer and method of grinding large sample quantities |
| JP7416496B1 (ja) * | 2023-03-03 | 2024-01-17 | 株式会社小泉製作所 | 粉砕器具 |
| JP2024180257A (ja) * | 2023-06-16 | 2024-12-26 | 株式会社小泉製作所 | 粉砕器具 |
| CN117511740B (zh) * | 2024-01-08 | 2024-05-10 | 山东伯桢生物科技有限公司 | 组织解离装置及用于组织解离装置的控制方法 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE738286C (de) * | 1940-11-16 | 1943-08-10 | Walter Guenther Dipl Ing | Verfahren zur Feinstzerkleinerung |
| US3172546A (en) * | 1961-05-19 | 1965-03-09 | Union Carbide Corp | Size reduction of biological substances |
| DE2057428A1 (de) * | 1970-11-21 | 1972-06-08 | Kloeckner Humboldt Deutz Ag | Schwingmuehle fuer die Zerkleinerung fester Stoffe unter Zugabe von Kaeltemitteln in den Mahlraum |
| EP0014179B1 (fr) * | 1979-01-18 | 1982-05-12 | Ciba-Geigy Ag | Dispositif pour extraire des composants de matières solides ou semi-solides |
| US4509695A (en) * | 1983-07-18 | 1985-04-09 | Spectrum Medical Industries, Inc. | Tissue pulverizer |
| JPH03186360A (ja) * | 1989-12-15 | 1991-08-14 | Sumitomo Electric Ind Ltd | ダイヤモンドまたは立方晶窒化硼素の破砕方法 |
| US6235501B1 (en) * | 1995-02-14 | 2001-05-22 | Bio101, Inc. | Method for isolation DNA |
| JPH11148890A (ja) * | 1997-11-17 | 1999-06-02 | Takahisa Matsue | 凍結試料破砕用容器 |
| JP2001178444A (ja) * | 1999-10-13 | 2001-07-03 | Yasui Kikai Kk | 破砕方法及び装置 |
| JP4373391B2 (ja) * | 1999-10-13 | 2009-11-25 | 安井器械株式会社 | 試料破砕用具 |
| JP2002066366A (ja) * | 2000-08-25 | 2002-03-05 | Japan Nuclear Cycle Development Inst States Of Projects | ボールミルポット内壁への粉末付着防止方法 |
| US6553190B1 (en) | 2001-10-16 | 2003-04-22 | Hewlett-Packard Development Co., L.P. | Correction of pulse width accumulator based on the temperature and relative humidity |
| JP4029998B2 (ja) * | 2001-10-17 | 2008-01-09 | 独立行政法人理化学研究所 | サンプル保存ケースおよびサンプル保存ケースの収容ラック |
| DE10153957A1 (de) | 2001-11-06 | 2003-05-22 | Quiagen Gmbh | Verfahren zur Isolierung von Nukleinsäuren |
| JP3793472B2 (ja) * | 2002-03-05 | 2006-07-05 | 安井器械株式会社 | 破砕装置 |
| EP1546383A4 (fr) * | 2002-09-17 | 2006-08-30 | Pharmacia Corp | Isolement de molecules geniques a partir d'une construction biologique complexe, a utiliser dans une analyse d'expression genique |
| EP1558765A4 (fr) | 2002-11-08 | 2005-11-30 | Pharmacia Corp | Methodes automatiques et productives d'isolation et de quantification d'acide nucleique |
| US20040144874A1 (en) * | 2003-01-24 | 2004-07-29 | Moskowitz Joel P. | Method and apparatus for making high purity silica powder by ball milling |
| GB2399518B (en) * | 2003-03-17 | 2005-04-13 | Freshcrush Ltd | Crushing apparatus |
| US20050178726A1 (en) | 2004-02-18 | 2005-08-18 | Robert Belly | Disruption of cells and tissues |
| GB2421448A (en) * | 2004-12-24 | 2006-06-28 | Levene Ltd William | Foodstuff crushing and blending apparatus |
| JP4903419B2 (ja) * | 2005-04-20 | 2012-03-28 | 安井器械株式会社 | 破砕方法とそれを用いた破砕装置及び破砕処理装置 |
-
2007
- 2007-04-04 DE DE102007016221A patent/DE102007016221A1/de not_active Ceased
-
2008
- 2008-04-02 US US12/594,479 patent/US8348183B2/en not_active Expired - Fee Related
- 2008-04-02 JP JP2010501502A patent/JP5150880B2/ja not_active Expired - Fee Related
- 2008-04-02 EP EP08735665.5A patent/EP2129467B1/fr not_active Not-in-force
- 2008-04-02 WO PCT/EP2008/053896 patent/WO2008122550A2/fr not_active Ceased
-
2012
- 2012-07-27 US US13/560,304 patent/US20130026268A1/en not_active Abandoned
Non-Patent Citations (1)
| Title |
|---|
| See references of WO2008122550A2 * |
Also Published As
| Publication number | Publication date |
|---|---|
| US20130026268A1 (en) | 2013-01-31 |
| WO2008122550A3 (fr) | 2009-03-19 |
| DE102007016221A1 (de) | 2008-10-09 |
| US8348183B2 (en) | 2013-01-08 |
| US20100137567A1 (en) | 2010-06-03 |
| JP2010523956A (ja) | 2010-07-15 |
| EP2129467B1 (fr) | 2014-07-02 |
| JP5150880B2 (ja) | 2013-02-27 |
| WO2008122550A2 (fr) | 2008-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2129467B1 (fr) | Pulvérisateur et procédé de préparation du traitement d'un échantillon biologique | |
| EP2166335B1 (fr) | Procédé et dispositif pour l'ouverture simultanée automatique de plusieurs échantillons biologiques | |
| EP1969341B1 (fr) | Procede de traitement d'un echantillon biologique | |
| DE69929445T2 (de) | Methoden und reagenzien zur erhaltung der rna in zellen und geweben | |
| EP2175996B1 (fr) | Procédé pour fixer/stabiliser un échantillon | |
| Eltsov et al. | Transmission electron microscopy of the bacterial nucleoid | |
| Bélanger et al. | A versatile enhanced freeze-substitution protocol for volume electron microscopy | |
| EP2434873B1 (fr) | Procédé et dispositif de conservation de noyaux cellulaires | |
| Kadan et al. | In situ electron microscopy characterization of intracellular ion pools in mineral forming microalgae | |
| DE102015221671B3 (de) | Gefäß für den Laboreinsatz | |
| US20060254912A1 (en) | System and method for treating biological tissue usiing curret electrical field | |
| Stanley et al. | Microstructure of rapeseed | |
| EP1534848B1 (fr) | Procede pour extraire des proteines | |
| Phillips et al. | Preparation of cell extracts by cryogrinding in an automated freezer mill | |
| Fornal et al. | The influence of hydrothermal treatment of rapeseeds on their selected physical properties and ability to crush during grinding | |
| EP1633868A1 (fr) | Procede pour obtenir un adn plasmidique au moyen d'un systeme biphasique aqueux | |
| EP2231853A2 (fr) | Procédé et trousse de travail pour la conservation d'échantillons et pour la désagrégation des cellules, avant l'extraction des acides nucléiques | |
| Tao et al. | Pressure cycling technology (PCT) applications in extraction of biomolecules from challenging biological samples | |
| DE102017106867B4 (de) | Verfahren zur Herstellung einer Portionseinheit | |
| Young et al. | Comparison of the Effects of Three Different Grinding Procedures on The Microstructure of" old-fashioned" Non-Stabilized Peanut Butter | |
| EP2529744A1 (fr) | Extraction de protéines à partir de macroalgues marines, procédés d'installation et d'utilisation | |
| DE60105396T2 (de) | Verfahren zur herstellung von pflanzlichen extrakten, damit erhaltene extrakten, und ihre verwendungen | |
| Merzlov et al. | Investigation of the process of bee pollen comminution | |
| DE102016213060A1 (de) | Gefäß für den Laboreinsatz | |
| DE102007025276A1 (de) | Aromatische Alkohole zur Behandlung einer biologischen Probe |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20090806 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR |
|
| 17Q | First examination report despatched |
Effective date: 20111024 |
|
| DAX | Request for extension of the european patent (deleted) | ||
| GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
| INTG | Intention to grant announced |
Effective date: 20140324 |
|
| GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
| GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
| AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR |
|
| REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D Free format text: NOT ENGLISH |
|
| REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 675608 Country of ref document: AT Kind code of ref document: T Effective date: 20140715 Ref country code: CH Ref legal event code: EP |
|
| REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Free format text: LANGUAGE OF EP DOCUMENT: GERMAN |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 502008011976 Country of ref document: DE Effective date: 20140814 |
|
| REG | Reference to a national code |
Ref country code: NL Ref legal event code: VDEP Effective date: 20140702 |
|
| REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20141002 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20141003 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140702 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20141002 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140702 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140702 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140702 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140702 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20141103 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140702 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140702 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140702 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140702 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20141102 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140702 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 502008011976 Country of ref document: DE |
|
| REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 8 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140702 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140702 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140702 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140702 |
|
| PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
| 26N | No opposition filed |
Effective date: 20150407 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150402 Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140702 Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140702 |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
| REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20150430 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20150430 |
|
| REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 9 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20150402 |
|
| REG | Reference to a national code |
Ref country code: AT Ref legal event code: MM01 Ref document number: 675608 Country of ref document: AT Kind code of ref document: T Effective date: 20150402 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20160421 Year of fee payment: 9 Ref country code: DE Payment date: 20160421 Year of fee payment: 9 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20150402 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20160427 Year of fee payment: 9 Ref country code: FR Payment date: 20160421 Year of fee payment: 9 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140702 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20080402 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20150430 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140702 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 502008011976 Country of ref document: DE |
|
| GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20170402 |
|
| REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST Effective date: 20171229 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170502 Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20171103 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170402 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170402 |